Total Payments
$2,744
2024 Payments
$571.18
Companies
26
Transactions
132
Medicare Patients
1,033
Medicare Billing
$62,383
Payment Breakdown by Category
Food & Beverage$2,557 (93.2%)
Education$187.48 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,557 | 123 | 93.2% |
| Education | $187.48 | 8 | 6.8% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$2,744
131 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $307.21 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $301.05 | 16 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $234.91 | 14 | $0 (2018) |
| Duchesnay USA Incorporated | $228.50 | 12 | $0 (2019) |
| Organon Llc | $217.13 | 12 | $0 (2024) |
| Avion Pharmaceuticals | $187.55 | 15 | $0 (2021) |
| AbbVie Inc. | $173.92 | 4 | $0 (2023) |
| CooperSurgical, Inc. | $172.29 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $137.48 | 7 | $0 (2024) |
| MILLICENT US INC | $127.28 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $571.18 | 27 | Astellas Pharma US Inc ($198.48) |
| 2023 | $233.77 | 11 | Astellas Pharma US Inc ($102.57) |
| 2022 | $217.97 | 10 | MAYNE PHARMA INC. ($70.52) |
| 2021 | $199.75 | 11 | Organon LLC ($65.92) |
| 2020 | $15.00 | 1 | MILLICENT US INC ($15.00) |
| 2019 | $471.55 | 25 | Avion Pharmaceuticals ($120.24) |
| 2018 | $715.94 | 28 | AMAG Pharmaceuticals, Inc. ($243.22) |
| 2017 | $319.24 | 19 | Vertical Pharmaceuticals, LLC ($144.83) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 12/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Biological | ||||||
| 11/26/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $34.27 | General |
| 11/25/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Diagnostics | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Biological | ||||||
| 11/08/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/07/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ETONOGESTREL | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: VACCINE | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Biological | ||||||
| 09/17/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 07/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Biological | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Biological | ||||||
| 07/18/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Endocrinology | ||||||
| 06/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Biological | ||||||
| 06/05/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: ETONOGESTREL | ||||||
| 05/23/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: WOMENS HEALTH | ||||||
| 05/16/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Diagnostics | ||||||
| 05/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Biological | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Biological | ||||||
| 04/10/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ETONOGESTREL | ||||||
| 03/20/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $34.60 | General |
| Category: Endocrinology | ||||||
| 03/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Biological | ||||||
| 02/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Biological | ||||||
| 02/14/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: HORMONE THERAPY | ||||||
| 01/18/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 336 | 362 | $25,663 | $20,197 |
| 2022 | 5 | 260 | 286 | $21,996 | $16,728 |
| 2021 | 5 | 281 | 309 | $21,210 | $16,177 |
| 2020 | 4 | 156 | 167 | $12,067 | $9,281 |
Total Patients
1,033
Total Services
1,124
Medicare Billing
$62,383
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 165 | $16,761 | $11,870 | 70.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 135 | 135 | $6,066 | $5,944 | 98.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 27 | 27 | $1,421 | $1,341 | 94.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $975.00 | $955.50 | 98.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 19 | 22 | $440.00 | $86.68 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 139 | $14,333 | $10,244 | 71.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 77 | 77 | $3,466 | $3,420 | 98.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 37 | 37 | $1,947 | $1,914 | 98.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $1,830 | $1,067 | 58.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 19 | 21 | $420.00 | $83.26 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 136 | $13,326 | $8,724 | 65.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 106 | 106 | $4,765 | $4,765 | 100.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 36 | 36 | $1,895 | $1,877 | 99.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 11 | 11 | $825.00 | $730.73 | 88.6% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 17 | 20 | $400.00 | $80.40 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 76 | $6,487 | $4,182 | 64.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 61 | 61 | $2,736 | $2,728 | 99.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 18 | $2,213 | $1,761 | 79.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 12 | 12 | $631.47 | $610.68 | 96.7% |
About Dr. Audrey Buxbaum, MD
Dr. Audrey Buxbaum, MD is a Obstetrics & Gynecology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265530679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Audrey Buxbaum, MD has received a total of $2,744 in payments from pharmaceutical and medical device companies, with $571.18 received in 2024. These payments were reported across 132 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,557).
As a Medicare-enrolled provider, Buxbaum has provided services to 1,033 Medicare beneficiaries, totaling 1,124 services with total Medicare billing of $62,383. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location New York, NY
- Active Since 09/20/2006
- Last Updated 12/13/2013
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1265530679
Products in Payments
- INTRAROSA (Drug) $307.21
- Veozah (Drug) $301.05
- NEXPLANON (Drug) $253.00
- DIVIGEL (Drug) $234.91
- Osphena (Drug) $228.50
- Balcoltra (Drug) $163.40
- LO LOESTRIN FE (Drug) $125.09
- Orilissa (Drug) $125.09
- Paragard (Device) $111.65
- Phexxi (Drug) $104.42
- APTIMA (Device) $89.77
- FEMRING (Drug) $73.34
- Paragard T 380A (Drug) $60.64
- MYFEMBREE (Drug) $59.90
- Femring (Drug) $53.94
- SOLOSEC (Drug) $35.77
- GARDASIL (Biological) $28.78
- Prenate Mini (Drug) $24.15
- Kyleena (Drug) $21.87
- IMVEXXY (Drug) $21.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in New York
Mary Polan, M.d, M.D
Obstetrics & Gynecology — Payments: $2.3M
Obstetrics & Gynecology $2.3M
Steven Goldstein, Md, MD
Obstetrics & Gynecology — Payments: $831,948
Obstetrics & Gynecology $831,948
Veronica Lerner, Md, MD
Obstetrics & Gynecology — Payments: $233,429
Obstetrics & Gynecology $233,429
Jian Qun Huang, M.d, M.D
Obstetrics & Gynecology — Payments: $212,396
Obstetrics & Gynecology $212,396
Carolyn Westhoff, M.d, M.D
Obstetrics & Gynecology — Payments: $185,820
Obstetrics & Gynecology $185,820
Dr. Lisa Eng, D.o, D.O
Obstetrics & Gynecology — Payments: $178,012
Obstetrics & Gynecology $178,012